Steriscience Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STERISCIENCE, and what generic alternatives to STERISCIENCE drugs are available?
STERISCIENCE has thirty-two approved drugs.
There are two US patents protecting STERISCIENCE drugs.
There are two patent family members on STERISCIENCE drugs in two countries and eighty-five supplementary protection certificates in eleven countries.
Summary for Steriscience
| International Patents: | 2 |
| US Patents: | 2 |
| Tradenames: | 25 |
| Ingredients: | 22 |
| NDAs: | 32 |
Drugs and US Patents for Steriscience
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steriscience Speclts | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 201025-004 | Apr 9, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Steriscience Speclts | VANCOCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 062812-003 | Nov 17, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Steriscience Speclts | OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 091486-002 | Aug 25, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Steriscience Speclts | VANCOCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 060180-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Steriscience Speclts | MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE | midazolam hydrochloride | INJECTABLE;INJECTION | 090315-002 | Nov 29, 2010 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Steriscience Drugs
Supplementary Protection Certificates for Steriscience Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2380576 | 20C1048 | France | ⤷ Sign Up | PRODUCT NAME: SEL DE SODIUM DE L'ACIDE DESOXYCHOLIQUE; NAT. REGISTRATION NO/DATE: NL46299 20180810; FIRST REGISTRATION: IS - IS/1/16/071/01 20160729 |
| 2380576 | SPC/GB20/050 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DEOXYCHOLIC ACID SODIUM SALT; REGISTERED: UK PL 45496/0009 20170526 |
| 0268956 | SPC/GB98/040 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508 |
| 0957929 | SPC/GB06/021 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PEGAPTANIB, PREFERABLY IN THE FORM OF ITS SODIUM SALT; REGISTERED: UK EU/1/05/325/001 20060201 |
| 1874117 | 2014/032 | Ireland | ⤷ Sign Up | PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTRATION NO/DATE: EU/1/13/892/001-002 20140121 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
